Cloverdale Capital Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Cloverdale Capital Management’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-324,722	Closed	-$6.17M	–	22
2019 Q1	$6.17M	Sell	324,722 -272,542	-46%	-$4.42M	3.39%	14
2018 Q4	$8.06M	Buy	+597,264	New	+$6.68M	5.69%	10

Other funds holding OSIR

FGAM

Financial Gravity Asset Management Lakeway, Texas $562M AUM

Cloverdale Capital Management's OSIR Position: Q2 2019 in Review

Cloverdale Capital Management sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 324,722 shares — an estimated $6.17M sold.

Cloverdale Capital Management first reported a position in OSIR in Q4 2018 and held it in 2 quarters. The position peaked at $8.06M in Q4 2018. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

Cloverdale Capital Management reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Cloverdale Capital Management sold 324,722 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $6.17M.
Cloverdale Capital Management first reported a position in Osiris Therapeutics, Inc. Common Stock in Q4 2018 and held it in 2 quarters.
Cloverdale Capital Management's Osiris Therapeutics, Inc. Common Stock position peaked at $8.06M in Q4 2018.
1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Cloverdale Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.